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Summary
Background: Reviewing patient characteristics of new patients attending NHS Addiction Services in Lanarkshire, an 
increase in new patients accessing treatment for opioid analgesics dependence (OAD) was identiied. This article con-
ducted to assist in the identiication of the characteristics of OAD patients that are presenting to addiction services in 
NHS Lanarkshire by using data collected, on the Europad-RADARs surveillance form, at the irst medical appointment 
on substances used in the 90 days prior to admission. Methods: A total of 217 patients had accessed the service in the 
time frame. Of these, 29 patients (13.3%) declared that their primary drug of misuse was a prescribed opioid analgesic. 
Results: The reported results demonstrated that 13 (45%) were female. Various routes of obtaining the medication were 
reported, including access to illicit markets and supplies.16 (55%) patients reported taking other medications in addi-
tion for a euphoric effect. In relation to chronic pain, as deined in the questionnaire, 10 (35%) of the patients reported 
to having chronic pain at some point in their life and 19 (65%) reported to have never attended a GP for chronic pain. 
Conclusions: The data collected demonstrates that there is a demand for addiction treatment services to be provided for 
patients who have been misusing prescribed opioid analgesic medications and the demand for these services appears to be 
increasing. As a result the services employed to address the issue and provide treatment for these patients may need to be 
adapted from the traditional illicit opioid user model.
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1. Introduction
From reviewing patient characteristics of new 
patients attending NHS Addiction Services in La-
narkshire it has been previously noted in the article 
by Hill [4] there has been an increase in new patients 
accessing treatment for dependence on opioid anal-
gesics. This was a signiicant difference in irst time 
attendees in comparison to returning patients. The 
report from this study also relected that the age of 
patients was increasing.
The full extent of the problem remain unknown 
within the UK and Europe, with much of the data be-
ing collected and reported coming from the US, al-
though trends in prescribed opioids are being moni-
tored and their growth noted in the UK and Europe.
The population misusing these medications is 
not limited by any age or gender speciicity, it was 
previously thought to be due to middle aged women 
from better socio economic backgrounds taking too 
many medicines, but this has been demonstrated not 
to be the case. 
The sole source of supply is not limited to the 
misuse of prescribed opioid analgesics but is also 
extended to the misuse of Over the Counter (OTC) 
medications which can be purchased at community 
pharmacies. This source of medication that can be 
misused can lead to a further untapped issue of con-
cern as the availability of these medications is com-
mon, and they are easily accessible to all [1]. Wright 
et al. [8] recently reported that the supply of OTC 
opioid analgesics that are being possibly misused 
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from community pharmacies in Scotland is now rec-
ognised by over 80% of the pharmacies. The possible 
misuse of opioid analgesics now being identiied is 
greater than that of the sleep aids sold. This has been 
further added to by a series of case studies [3, 5, 7] 
which have highlighted the issues of patients becom-
ing dependent on OTC opioid analgesic preparations.
Further report on a study undertaken in com-
munity pharmacies in Scotland is also being inalised 
but shows differences to populations misusing OTC 
medications from a self report form issued to patients 
buying these medications from community pharma-
cies in Scotland. This has encouraged the Royal Phar-
maceutical Society in Scotland to develop training 
for pharmacists and pharmacy staff on identiication 
and responses to potential misuse of OTC problems. 
These sessions have been supported by the awareness 
fact sheets issued by the RCGP [6].
The access to opioids may exist from numerous 
sources, from OTC purchases, supply from friends 
and family, prescriptions from GPs and people sell-
ing drug illicitly. These all have inherent risks both to 
the individual consuming the medication, e.g. over-
dose risks, additional ingestion of other substances 
on combined products and their toxic effects e.g. par-
acetamol or ibuprofen, and sub-therapeutic dosing of 
friends or family who may be diverting some of their 
medication to others (either by selling or giving away 
their prescribed medication). The risks are seldom 
presented to both the suppliers but more importantly 
the users of the medication, and they will probably be 
unaware of the risks of exceeding the recommended 
doses of medicines and duration of recommended 
treatment before seeking medical advice. The source 
of the medicines used may also change dependent 
on the time taken for individuals to realise there is 
a reason for concern and need for treatment. A case 
study by Conroy and Hill [2] demonstrates the pro-
gression from prescribed medication, to illicit use and 
then treatment, before relapse due to prescription and 
subsequent return to treatment, this is echoed by the 
case example from Marr and Hill, where there was 
prescription use, subsequent OTC purchased and as-
sistance from family to obtain the analgesics before 
accessing treatment [5].
Patient perception as identifying themselves as 
an individual dependent on opioid analgesics is often 
a challenge, as many start to take these medications 
for valid and legitimate reasons and conditions [1, 2, 
3, 5] but this lead to the individuals continuing to take 
the medication for different reasons. The self identii-
cation of being dependent and having an addiction is 
dificult as this group of individuals try to distinguish 
themselves as different to individuals with other ad-
dictions e.g. illicit drugs or alcohol [1]. The issues of 
stigma and treatment are also becoming more com-
mon, and service redesign to cater for this patient 
group is still required, but as the scale of the issue has 
not been clearly identiied, the level of service pro-
vision required has also not been clearly projected. 
Suggestions on service development and reduced 
stigma have been mentioned in some articles [5] but 
there is as yet no set standard or practice that has been 
identiied as more suitable than other models.
NHS Lanarkshire collect data on all new pa-
tients accessing treatment for addiction issues and are 
a data collection site for the Europad/RADARs sur-
veillance initiative. The Europad – Radars initiative 
is collecting data from patients on the substances they 
have used to gain a euphoric experience in the pre-
vious 90 days prior to accessing treatment. The data 
is being collected from 10 sites throughout Europe, 
and is being co-ordinated and collected by Europad 
in Italy, who are working with the RADARs group 
from Rocky Mountain Drug Poison Centre in Denver, 
Colorado, US.
This article has been developed to follow on the 
initial studies conducted to assist in the identiica-
tion of the characteristics of OAD patients that are 
presenting to addiction services in NHS Lanarkshire. 
The routes of access vary between individuals, rang-
ing from self referral to directed access to the services 
via GPs, however third parties such as Social work, 
family or pharmacies can also refer individuals to ser-
vices.
No ethical approval is required for this study as 
the patient information is anonymous and there will 
be no impact on treatment provided as a result of the 
information provided by the patients.
This studies aim is to identify from the RADARs 
data, the characteristics of patients who have present-
ed to the addictions services in NHS Lanarkshire with 
a reported dependency on prescribed opioid analge-
sics.
2. Methods
The patients complete the Europad RADARs 
surveillance questionnaire at the initial medical with 
the Addiction Service General Practitioner before 
commencing on a prescription. The form collates a 
number of demographics and details relating to the 
patient, their drug of choice, overdose history, source 
of medications, substances used to get ”high” in the 
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previous 90 days and access/treatment for chronic 
pain. 
3. Results
At the time of collecting data, 217 patients had 
accessed the service completing the Europad RA-
DARs data collection form. 
From this sample 29 patients (13.3%) declared 
that their primary drug of misuse was a prescribed 
opioid analgesic (irrespective of source of supply). 
An anonymised individual breakdown of the patients 
responding with a reported primary drug that is an 
opioid analgesic can be seen in Table 1.
From the cohort of 29 patients, the primary drugs 
were noted as 19 (66%) codeine, 6 (21%) tramadol, 3 
(10%) DHC and 1(3%) morphine.
Previous treatment episodes: 86% (25) had not 
previously been in treatment, 2 (7%) had accessed 
treatment once previously and 2 (7%) have accessed 
multiple times. It is also worth noting 2 patients also 
reported to being currently in methadone assisted 
treatment.
Of the 29 reporting to use prescribed opioid an-
algesics, the patient demographics demonstrated that 
13 (45%) were female. The average age of the cohort 
was 36 years.
When reviewing the source of the opioid analge-
sic, there are various routes of obtaining the medica-
tion that are displayed in Table 2.
Two reported overdoses on prescribed medica-
tion in the previous 90 days, and two other individu-
als admitted an overdose on prescribed medication 
,more than 90 days ago.
16 (55%) patients reported taking other medica-
tions in order to get “high”. These other medications 
included other prescription opioids such as trama-
dol, fentanyl, and codeine, opioid agonist medica-
tion (e.g. Subutex and methadone), OTC medications 
(e.g. Night nurse (paracetamol, dextromethorphan 
Table 1: Patient details – anonymised
Num-
ber
Gen-
der
Age 
group
Primary 
drug 
Previous 
treatment
Source (s) Other drugs taken to get high
Chronic 
pain (ever)
1 M 30's Tramadol N Dealer Codeine, Heroin, Benzodiazepines N
2 F 30's Codeine N Pharmacy (bought) Y
3 F 20's Tramadol Y - 1 Dealer
Buprenorphine, THC, Gabapentin, 
Benzodiazepine
N
4 M 30's Tramadol N GP Rx Y
5 M 50's Tramadol N GP Rx Y
6 M 40's Codeine N GP Rx Tramadol Y
7 F 20's Codeine N Dealer N
8 M 30's Codeine N Pharmacy (bought) N
9 F 30's Tramadol N
Internet, prescribed, 
stole
Codeine N
10 F 40's Codeine Y - 1 Pharmacy (bought) THC Y
11 F 40's Codeine
Y - MUL-
TIPLE
Dealer Benzodiazepine Y
12 M 40's Codeine N Pharmacy (bought) THC N
13 F 30's Codeine N Pharmacy (bought) NIGHT NURSE N
14 F 40's Codeine N Friend/relative N
15 M 30's Codeine N Pharmacy (bought) N
16 M 40's Codeine N GP Rx Benzodiazepine Y
17 M 40's Codeine N GP Rx Y
18 F 30's
Dihy-
droco-
deine
N GP Rx N
19 F 30's
Dihy-
droco-
deine
N GP Rx Y
20 M 30's Codeine N
Dr RX, Friends rela-
tive, A&E
Tramadol (oral and injection), 
Gabapentin
N
21 M 20's Codeine N GP Rx N
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and promethazine (a cold and lu remedy)), prescrip-
tion gabapentinoids (e.g. pregabalin, gabapentin) and 
other illicit drugs, including cannabis and cocaine. 6 
patients (20%) declared benzodiazepine use in the 
previous 90 days to get “high” (i.e. for euphoric ef-
fects, not for therapeutic dosing or treatment) before 
accessing treatment. The range of other substances 
used extended from 1 to 6 different drugs taken by a 
single individual.
5 of the responders admitted accessing dealers, 
but a further 5 individuals reported to purchasing/ac-
cessing cannabis or benzodiazepines in addition to 
the opioids, suggesting they have possible access to 
illicit markets (sources) increasing the possibility of 
10 patients (35%) have access to illicit markets and 
supplies
Of the seldom used sources A&E, internet and 
theft only account for one individual each and these 
options are not the sole source for the individuals ac-
cessing in this manner.
In response to the questions relating to the pa-
tients suffering from chronic pain, 10 (35%) of the 
patients responded to having chronic pain as deined 
in the data collection form (which is “Pain that has 
lasted for at least 3 months, which occurs constantly 
or lares up frequently”).
When asked to put a time frame on the last ap-
pointment with their GP in relation to the pain, 19 
(65%) reported to have never attended a GP for 
chronic pain, 3 (10%) had presented within the last 7 
days, 4 (14%) in the last 30 days and 3 (10%) within 
the last year.
2 of the 6 individuals reporting to only misusing 
OTC medications admitted to suffering from chronic 
pain at some point in their life as deined in the ques-
tionnaire.
Table 1: Patient details – anonymised
Num-
ber
Gen-
der
Age 
group
Primary 
drug 
Previous 
treatment
Source (s) Other drugs taken to get high
Chronic 
pain (ever)
22 F 30's
Dihy-
droco-
deine
N Friend/relative Codeine N
23 M 20's Codeine N Friend/relative
Tramadol, THC, Amitriptyline, 
Gabapentin
N
24 M 20's Tramadol N Friend/relative Codeine, Benzodiazepine N
25 M 30's Codeine N
GP Prescription, 
Friend relative
N
26 F 30's Codeine N
GP Prescription, 
Friend relative
Y
27 M 20's Codeine N
GP Prescription, 
Friends, Pharmacy
Fentanyl N
28 M 30's Morphine Y - 5 Dealer
Tramadol, Methadone, Subutex, 
Codeine, THC, Pregabalin
N
29 F 40's Codeine N Friend/relative
Tramadol, Cocaine, Benzodi-
azepine
N
Table 2: Source of supply of medication
Source declared Number of patients * Only source Multiple sources
Dealers 5 5 (17%) 0
Over the counter (Pharmacy sale) 7 6 (20%) 1 (3%)
Friends and relatives 9 5 (17%) 4 (14%)
GP prescribed 13 8 (27%) 5 (17%)
Internet 1 1 (3%)
A&E 1 1 (3%)
Stolen 1 1 (3%)
*Number of patients will add up to more than 29 as some are accessing from multiple sources
- 23 -
D. Hill: Characteristics of patients accessing NHS Lanarkshire Addiction Services for the treatment of Opioid Analgesic Dependence
4. Discussion
The patients accessing the addictions service 
with dependency on opioid analgesics are a new 
group to access treatment in NHS Lanarkshire, 86% 
of the patients are accessing services for the irst time 
which highlights that these are new patients and have 
not reported to be in treatment previously.
The expected demographics of a more mature 
female from a mid to very afluent background who 
took too many pills (of medication they had been pre-
scribed) through boredom can be challenged. 
The gender difference is a different proportion 
to that seen with tradition illicit opioid misusers. The 
traditional group tend to have a ratio of 3 males: 1 fe-
male (this ratio is also seen with the RADARs sample 
as a whole), however with the group misusing opioid 
analgesics the male female ratio is reported to be 
much closer at nearing 1:1. 
The ages are fairly consistent between the whole 
sample and the opioid analgesic groups, but this is to 
be expected as the age of illicit drug misusers access-
ing the services has increased in general. This is also 
the age range identiied in the previous study [4].The 
reported overdose history from these patients is of 
concern, 4 of the 29 (13.8%) reported to have had an 
overdose previously, 2 (6.9%) within the last 90 days 
and 2 (6.9%) in a longer time period. This highlights 
an area of concern and an issue that needs to be ad-
dressed by awareness raising both for prescribers/pro-
viders (e.g. GPs and pharmacies) of opioid analgesics 
(self awareness of the risks but also patient education 
requirements) and for the patients themselves.
13 (45%) of the surveys reported that the indi-
viduals were not using any other substance than the 
one declared as their primary substance, however the 
other 55% (16 patients) admitted using other sub-
stances. There is a wide spread of other substances, in 
addition to the primary drug, reported to being con-
sumed ranging from a single other OTC medication 
(Night Nurse) or prescription medication (including 
tramadol, fentanyl) or illicit drug (cannabis) through 
to 6 different substances (which included cannabis, 
pregabalin and 4 opioid substances). The consump-
tion of other substances in addition to the primary 
misuse of an opioid carries an increased risk of over-
dose and again highlights the needs for patients to be 
aware of the dangers and recognition to signs of over-
dose and actions to take in the event of witnessing 
an overdose. The availability of naloxone to reverse 
opioid overdoses is widely available through addic-
tion services in Scotland and can also be prescribed 
by GPs, and this should be considered for patients 
who are at risk of overdose due to consumption of 
opioid medications. The propensity of the patients 
misusing medications for the consumption of mul-
tiple medications/substances demonstrates a similar 
afinity to poly pharmacy exhibited by “traditional” 
illicit drug users.
The range of sources of the opioid analgesics 
is wide, 24 of the 29 patients (83%) are reporting to 
only use a single source for their opioid analgesic, 
and however 5 report multiple sources. There is a 
high number (17%) that access the medication only 
through dealers, but a further 17% also report to us-
ing either cannabis or benzodiazepines in addition to 
opioids which demonstrates possible links to dealers 
of illicit medication.
Literature has reported that many patients mis-
using opioid analgesics may have been introduced to 
the medication through genuine reasons [1, 2, 3, 5] 
and they have been initially prescribed by the GPs to 
treat the presenting condition, 45% of the group re-
ported to have being prescribed opioid medications 
from their GP and for nearly two thirds of this the 
GP remains the sole source of medication. It should 
be noted that not all the patients report to being pre-
scribed for chronic pain, although 10 (35%) do have 
a reported diagnosis from their GP. With 27% of the 
sample reporting to only accessing the medication by 
prescriptions for their GP, there is a need and oppor-
tunity to provide interventions and review. Raising 
the issue of opioid analgesic dependence and support-
ing awareness using materials e.g. RCGP factsheets 
at both GP surgeries and community pharmacies will 
possibly provide an intervention and reduction in pos-
sible misuse. Other sources of reference [1, 3] also 
highlight the initial use of the medication may be for 
reasons other than pain but to induce a euphoric sen-
sation [6].
20% of the sample report to only purchasing the 
opioids used from pharmacies, this is a practice they 
may have found as easy but it can be also very risky. 
There is easy and ready access to the medication 
through community pharmacies, and there is noth-
ing to prevent patients attending and purchasing OTC 
opioid medication from multiple pharmacies within 
a single day. An additional risk to the potential for 
respiratory depression associated with opioid for the 
patients purchasing opioids in this manner in addition 
are the toxic effects from the other drugs included in 
the combined preparations, e.g. paracetamol – hepa-
totoxicity and ibuprofen – nephrotoxicity and gastric 
irritation. In the quest for the opioid effects patients 
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may choose to ignore these and the advice provided 
in the community pharmacies increasing the risk or 
long term effects and ill health. Very high levels of 
combined analgesics are sometimes taken [7]. With 
these associated dangers and the possible lack of 
awareness of the general population to the risks as-
sociated with passing medication, either for free or 
for inancial reward, there is a need for an awareness 
raising campaign for the general public to the poten-
tial problems this issue may cause. 
The less used sources are theft, A&E attendance 
and internet and only seem to be used by patients us-
ing multiple sources of supply. This can be viewed 
as positive as there may be checks completed us-
ing Electronic Care Summaries by A&E and Out of 
Hours (emergency) services to prevent access to the 
medication from more than one source in the NHS, 
despite good availability to internet in Scotland, this 
market is not reported to be commonly used and that 
patients are not frequently stealing from others indi-
viduals prescribed the medication.
Two patients reported to having a current pri-
mary drug of misuse that was an OTC medication and 
source, despite being in treatment with methadone 
for previous opioid misuse, this highlights the need 
for all treatment services to fully assess patients and 
provide advice on medication use, including OTCs. 
This further emphasises the need for all individuals 
involved in patient care to fully review patients, but 
also share information e.g. a patient possibly misus-
ing opioid analgesics purchased OTC, whilst in treat-
ment with methadone. 
As the paper is demonstrating, there is a demand 
for addiction treatment services for patients who have 
been misusing prescribed opioid analgesic medica-
tions, and the demand appears to be increasing, and 
will be expected to continue to do so, as a result the 
services employed to address the issue and provide 
treatment for these patients need to be adapted. Marr 
and Hill [5] made numerous suggestions for con-
sideration with regards to treatment provision and 
some of the aspects that should be considered when 
developing services, these included issues such as 
clinic location, assessment, dispensing/supervision 
arrangements and stigma reduction associated with 
treatment.
Limitations
Data collected was on a validated form, agreed 
by a multinational group. This may not collect some 
of the additional data such as employment status 
which may be of interest.
The data collection area is a single health board 
in Scotland and only from the addictions service en-
trances to treatment, which may exclude some pa-
tients accessing services for the treatment of opioid 
analgesic dependency, which may be delivered by the 
GP.
5. Conclusions
The data collected demonstrates that there is a 
demand for addiction treatment services to be pro-
vided for patients who have been misusing prescribed 
opioid analgesic medications and the demand for 
these services appears to be increasing. As a result the 
services employed to address the issue and provide 
treatment for these patients may need to be adapted 
from the traditional illicit opioid user model.
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